A phenotypic defect in DNA repair renders FA patients sensitive to alkylating agents such as cyclophosphamide ; however, at lower doses, Cy is well tolerated in the FA transplant setting."
http://www.hispanicbusiness.com/2013/10/16/study_findings_from_fred_hutchinson_cancer.htm
http://www.hispanicbusiness.com/2013/10/16/study_findings_from_fred_hutchinson_cancer.htm
No comments:
Post a Comment